Kadryn Kadasia
Papers
1
Total Citations
1
H-Index
1
About
Kadryn Kadasia is a biomedical engineer whose research lies at the critical intersection of drug delivery, vaccinology, and global health equity. Her primary focus is on developing innovative, single-administration vaccine platforms designed to overcome the logistical barriers that plague immunization efforts in low- and middle-income countries (LMICs). Kadasia’s most notable contribution is the fabrication of pulsatile polymeric microparticles that encapsulate rabies antigen, a breakthrough aimed at replacing the standard multi-dose rabies post-exposure prophylaxis regimen. This work directly addresses a life-threatening gap: while rabies remains a deadly threat primarily in LMICs, the current requirement for multiple clinic visits over weeks is often impossible for at-risk populations. By engineering a single injection that releases antigen in controlled pulses, her research has the potential to dramatically simplify treatment, improve compliance, and save lives. Though her foundational paper on this topic has garnered initial citations, the profound public health implications of her work signal a rising impact. Kadasia’s research exemplifies how targeted biomaterials design can translate into tangible solutions for the world’s most neglected diseases.
Research Focus
Key Achievements
Top Papers
- 1